Magnetic Resonance Spectroscopic Analysis of Multifidus Muscle Lipid Contents and Association with Nociceptive Pain in Chronic Low Back Pain

다국어 초록 (Multilingual Abstract)

Study Design: Cross-sectional study.Purpose: This study aimed to analyze the differences in the lipid contents in chronic low back pain (CLBP) patients with nociceptive pain (NocP) and neuropathic pain (NeP) using magnetic resonance spectroscopy (MRS) of the multifidus muscle (Mm).Overview of Literature: Early identification of the pain characteristics with CLBP is important because specific treatment approaches are required, depending on NocP and NeP.Methods: The participants were 50 patients with CLBP (23 men and 27 women; mean age, 63.1±17.8 years; range, 41–79 years). We compared the Visual Analog Scale (VAS) scores, intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) of the Mm in NocP and NeP groups, as evaluated with the Japanese NeP screening questionnaire.Results: The patients were categorized into the NocP (n=32) and NeP (n=18) groups. The mean VAS score of the NocP group was 59.3±3.1 mm and that of the NeP group was 73.6±4.6 mm. The mean VAS score was significantly higher in the NeP group as compared to that in the NocP group (p<0.01). As per the analysis of covariance for the VAS score, the mean IMCL levels of the Mm in the NocP and NeP groups were 722.3 mmol/L (95% confidence interval [CI], 611.4–833.1) and 484.8 mmol/L (95% CI, 381.1–588.5), respectively. The mean IMCL level was significantly higher in the NocP group than in the NeP group (p<0.05). The mean EMCL levels of the Mm for the NocP and NeP groups were 6,022.9 mmol/L (95% CI, 4,510.6–7,535.2) and 5,558.1 mmol/L (95% CI, 4,298.3–6,817.9), respectively; however, the difference was not significant (p=0.72).Conclusions: The results indicated an association between the IMCL level of the Mm and NocP. Our results suggest that MRS of the Mm might be beneficial for the assessment of CLBP as well as appropriate targeted analgesic therapies.

참고문헌 (Reference)

1 Woolf CJ, "Towards a mechanism-based classification of pain?" 77 : 227-229, 1998

2 Dyck DJ, "The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity" 186 : 5-16, 2006

3 Wilke HJ, "Stability increase of the lumbar spine with different muscle groups : a biomechanical in vitro study" 20 : 192-198, 1995

4 Amouzou C, "Skeletal muscle insulin resistance and absence of inflammation characterize insulin-resistant grade I obese women" 11 : e0154119-, 2016

5 Tesarz J, "Sensory innervation of the thoracolumbar fascia in rats and humans" 194 : 302-308, 2011

6 Freynhagen R, "Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression : a prospective observational pilot study(MIPORT)" 22 : 529-537, 2006

7 Boesch C, "Role of proton MR for the study of muscle lipid metabolism" 19 : 968-988, 2006

8 Ogon I, "Quantitative analysis concerning atrophy and fat infiltration of the multifidus muscle with magnetic resonance spectroscopy in chronic low back pain" 3 : 163-170, 2018

9 Yamashita T, "Prevalence of neuropathic pain in cases with chronic pain related to spinal disorders" 19 : 15-21, 2014

10 Boesch C, "Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy" 904 : 25-31, 2000

11 Baron R, "Neuropathic pain : diagnosis, pathophysiological mechanisms, and treatment" 9 : 807-819, 2010

12 Boesch C, "Musculoskeletal spectroscopy" 25 : 321-338, 2007

13 Izaya Ogon, "Multifidus Muscles Lipid Content Is Associated with Intervertebral Disc Degeneration: A Quantitative Magnetic Resonance Imaging Study" 대한척추외과학회 13 (13): 601-607, 2019

14 Ogon I, "Magnetic resonance spectroscopic analysis of multifidus muscles lipid content and association with spinopelvic malalignment in chronic low back pain" 90 : 20160753-, 2017

15 Deyo RA, "Low back pain" 344 : 363-370, 2001

16 Torriani M, "Intramyocellular lipid quantification : repeatability with 1H MR spectroscopy" 236 : 609-614, 2005

17 Takashima H, "Evaluation of intramyocellular and extramyocellular lipids in the paraspinal muscle in patients with chronic low back pain using MR spectroscopy : preliminary results" 89 : 20160136-, 2016

18 Provencher SW, "Estimation of metabolite concentrations from localized in vivo proton NMR spectra" 30 : 672-679, 1993

19 Taylor RS, "Epidemiology of refractory neuropathic pain" 6 : 22-26, 2006

20 Velan SS, "Distinct patterns of fat metabolism in skeletal muscle of normal-weight, overweight, and obese humans" 295 : R1060-5, 2008

21 Suzuki H, "Diagnosis and characters of non-specific low back pain in Japan : the Yamaguchi low back pain study" 11 : e0160454-, 2016

22 Ogawa S, "Development of new screening questionnaire to identify neuropathic components in Japanese patients with chronic pain" 31 : 1187-1194, 2010

23 Srikanthan P, "Characterization of intra-myocellular lipids using 2D localized correlated spectroscopy and abdominal fat using MRI in type 2 diabetes" 5 : 29-36, 2012

24 Haanpaa ML, "Assessment of neuropathic pain in primary care" 122 (122): S13-S21, 2009

25 Weis J, "Assessment of lipids in skeletal muscle by LCModel and AMARES" 30 : 1124-1129, 2009

26 Ranger TA, "Are the size and composition of the paraspinal muscles associated with low back pain? : a systematic review" 17 : 1729-1748, 2017

27 Takashima H, "Analysis of intra and extramyocellular lipids in the multifidus muscle in patients with chronic low back pain using MR spectroscopy" 91 : 20170536-, 2018